Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
...senior positions with Fidelity Capital in Boston and Arthur Andersen LLP. He serves as director and chairman of the audit committee for two companies: celsion Corp., an oncology drug development company since 2005; and SCOLR Pharmaceuticals, a drug delivery company since 2007. Mr. Weaver is a certified publi...MIT radar technology fights breast cancer
...y of Oklahoma in Oklahoma City, Comprehensive Breast Center in Coral Springs, Fla., St. Josephs Hospital in Orange, Calif., and five additional sites. celsion (Canada) Limited licenses the focused microwave thermotherapy technology from MIT, and has produced 10 clinical systems to date to perform the procedu...Celsion Completes Enrollment in Phase I Liver Cancer Study
... COLUMBIA, Md.--(BUSINESS WIRE)--May 30, 2007 - celsion CORPORATION (AMEX:CLN) today announced the complet...study for Primary Liver Cancer later this year." celsion has licensed the global rights to the temperature-...well, the principal investigator. About Celsion: celsion is dedicated to the development and commercializat...Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
...Prior to joining Vion, Dr. Hahne, 54, was Vice President, Clinical Development, and then Vice President of Clinical Development and Medical Affairs of celsion Corporation from January 2006 to December 2007. From 2003 to 2005, Dr. Hahne was Vice President of Clinical Development for CuraGen Corporation. From ...Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
...as Executive Vice President, Chief Financial and Chief Operating Officer of celsion Corporation, a biotechnology company headquartered in Columbia, Maryland. At Celsion, Mr. Deasey played a key role in transitioning celsion from a medical device to an oncology drug development company, and acquired...